WBR0902: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 26: | Line 26: | ||
Educational objective: | Educational objective: | ||
[[File:Antagonist table.PNG]] | |||
|AnswerA=[[Naloxone]] and [[morphine]] | |AnswerA=[[Naloxone]] and [[morphine]] | ||
|AnswerAExp=Naloxone is a competitive antagonist of morphine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right. | |AnswerAExp=Naloxone is a competitive antagonist of morphine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right. |
Revision as of 16:20, 4 December 2013
Author | [[PageAuthor::Rim Halaby, M.D. [1]]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Pharmacology |
Sub Category | SubCategory::General Principles |
Prompt | [[Prompt::A researcher is investigating the effects of two drugs A and B on blood pressure in rats. The graph below shows the maximal effect of A in decreasing blood pressure when administered alone or when administered in combination with B. Which of the following combinations has an interaction similar to that of A and B?]] |
Answer A | [[AnswerA::Naloxone and morphine]] |
Answer A Explanation | AnswerAExp::Naloxone is a competitive antagonist of morphine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right. |
Answer B | [[AnswerB::Atropine and acetylcholine]] |
Answer B Explanation | AnswerBExp::Atropine is a competitive antagonist of acetylcholine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right. |
Answer C | [[AnswerC::Haloperidol and dopamine]] |
Answer C Explanation | AnswerCExp::haloperidol is a competitive antagonist of dopamine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right. |
Answer D | [[AnswerD::Ondansetron and serotonin]] |
Answer D Explanation | AnswerDExp::Serotonin is a competitive antagonist of ondansetron. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right. |
Answer E | [[AnswerE::Noreprinephrine and phenoxybenzamine]] |
Answer E Explanation | AnswerEExp::Phenoxybenzamine is a noncompetitive inhibitor of norepinephrine. An increase in the concentration of norepinephrine is not able to overcome the effect of phenoxybenzamine . |
Right Answer | RightAnswer::E |
Explanation | [[Explanation::Efficacy is defined as the maximal effect a drug can produce. While a full agonist produces maximal effect, a partial agonist only leads to less effect when compared to a full agonist.
Potency is defined effect is produced for a given concentration of a drug. The lower the concentration of a substance to produce an effect, the higher the affinity of the substance to the receptor and hence the higher the potency. According to the figure, when A is alone, a maximal effect is produced. However, when A and B are combined the curve is shifted downwards depicting decreased efficacy. An increase in the concentration of A was not able to overcome the effect of B on the efficacy. Hence B is a non-competitive inhibitor. Phenoxybenzamine is a noncompetitive inhibitor of norepinephrine. Educational objective: |
Approved | Approved::No |
Keyword | |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |